Certified by Founder Lodge
Actym Therapeutics, Inc.
United States - Berkeley, CA
START UP
1 Disclosed Funding Rounds $59,500,000
0 Participating Investments
-
Founded date
2017
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Actym Therapeutics is a cutting-edge biotech focused on the discovery and development of novel immuno-oncology therapies.
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| October, 20 ,2023 | Series A | $59,500,000 |
Illumina Ventures
Boehringer Ingelheim
Panacea Venture
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Transaera, Inc. | $10,500,000 | (Nov 5, 2024)
Algebrik AI | $4,000,000 | (Nov 5, 2024)
Insider. | $500,000,000 | (Nov 5, 2024)
Cintoo | $40,246,701 | (Nov 5, 2024)
Advex AI | $3,500,000 | (Nov 5, 2024)
